Commentary

Video

The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD

Vision correction has evolved into a continuum of procedures suited for different stages of ocular maturity

As part of the celebration of Ophthalmology Times’ 50th Anniversary, George O. Waring IV, MD, FACS, medical director of the Waring Vision Institute in Mount Pleasant, South Carolina, highlights 5 decades of advancements in cornea, cataract, and refractive surgery, emphasizing the evolving concept of “vision for a lifetime.” This approach ensures that vision correction procedures are available for every stage of ocular maturity, integrating corneal and lens-based refractive strategies.

Technological progress has significantly improved diagnostics, with high-resolution imaging, posterior corneal measurements, wavefront sensors, and visual simulators enhancing precision in refractive decision-making. Software now synthesizes diagnostic data, optimizing safety and outcomes.

In corneal and refractive surgery, high-speed lasers with advanced trackers enable rapid, precise treatments, enhancing visual quality and nighttime vision. FDA-approved corneal cross-linking has revolutionized keratoconus management, reducing the need for penetrating keratoplasties. Combining cross-linking with corneal reshaping techniques has further improved outcomes.

Lens-based refractive surgery has also seen substantial innovation. The EVO phakic IOL eliminates the need for laser peripheral iridotomies and offers toric correction, making it a viable alternative to LASIK for a broader patient population. For presbyopia, the concept of dysfunctional lens syndrome has led to a shift toward custom lens replacement, addressing both distance and near vision by targeting the root cause.

Refractive cataract surgery has been transformed by advanced IOL technology, including extended and full-range vision lenses, modular and exchangeable IOLs, and upcoming accommodative IOLs. Laser-assisted cataract surgery has also improved precision, safety, and astigmatism correction.

Looking ahead, emerging technologies such as transepithelial treatments, ray tracing, and hybrid laser techniques promise to refine refractive surgery further. The future also holds potential for presbyopia-correcting phakic IOLs and early intervention with lens-based solutions, ensuring continued advancements in achieving optimal lifelong vision.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.